Merck & Co. , Inc. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Merck & Co. with three other
companies in this sector in UNITED STATES :
Bayer AG
(2019
sales of $48.67 billion
of which 46%
was CropScience),
Novartis AG
($48.62 billion
of which 78%
was Innovative Medicines), and
GlaxoSmithKline plc
($43.18 billion
of which 52%
was Pharmaceuticals).
Sales Analysis.
Merck & Co. reported sales of $46.84 billion
for the
year ending
December of 2019.
This
represents
an
increase of 10.7%
versus 2018, when the company's sales were $42.29 billion.
This was the fourth straight year of sales growth at Merck & Co. .
Sales of Unallocated saw an increase
that was more than double the company's growth rate: sales were up
264.3% in 2019, from
$143.00 million to $521.00 million.
Not all segments of Merck & Co. experienced an increase in sales in 2019:
sales of All Other fell 30.0% to $175.00 million.
(However, this segment's sales were only a very small portion of the company's overall sales).